PharmAssist by ApoWiser

ApoWiser operates as a digital health company providing a platform for personalized, automated, and evidence-based health guidance. Founded in January 2021 by Prof. Eyal Schwartzberg and Alon Sudri, the company aims to enhance patient self-care and medication management. Prof. Schwartzberg, the Chief Scientific Officer, previously served as the Head of the Pharmaceutical & Enforcement Divisions of the Israeli Ministry of Health, bringing extensive regulatory and pharmaceutical knowledge to the venture. The firm is headquartered in Ra'anana, Israel.

The company's core business revolves around its proprietary system, PharmAssist, a digital platform designed for pharmacy chains and pharmaceutical companies. This system functions as a virtual pharmacist, assisting consumers in making informed decisions about Over-the-Counter (OTC) medications. The platform's business model serves multiple stakeholders. For pharmacy chains, it aims to increase sales conversion and average cart value by integrating into their online and offline channels, addressing labor shortages without additional labor costs. For pharmaceutical companies, it provides a marketing and sales channel that offers detailed insights into consumer behavior. Consumers benefit from a discreet, personalized tool that helps them select suitable OTC products based on their condition, allergies, and potential sensitivities.

PharmAssist covers over 600 OTC drugs and more than 40 healthcare scenarios, functioning as a chatbot-based system to guide users. In addition to the OTC solution, ApoWiser offers Apo-Rx, a digital navigator for prescription medications designed to improve patient adherence and provide valuable data insights to pharmaceutical companies. The company has established partnerships with drugstore chains in Israel and the UK, and is already in use by Super-Pharm, Israel's largest drugstore chain. In June 2022, ApoWiser secured $1.5 million in a seed funding round led by Longliv Ventures, a member of CK Hutchison Holdings, to support its global expansion.

Keywords: digital health, personalized health guidance, medication management, self-care platform, virtual pharmacist, Over-the-Counter drugs, OTC guidance, patient engagement, pharmacy technology, pharmaceutical marketing, consumer health, medication adherence, chatbot, Prof. Eyal Schwartzberg, Alon Sudri, Longliv Ventures, Super-Pharm, digital therapeutics, health data insights, pharmacy retail